COMMUNIQUÉS West-GlobeNewswire

H1 2024 Results - Focus-27 strategic plan on track with timely execution of the operational roadmap
30/07/2024
Press Release Paris, 30th July 2024 Net Sales down 9.6% year-on-year – Core EBITDA margin at 10.6% Accelerated commercial momentum with clients other than Sanofi, with Net Sales up 2.9%, excluding the Brindisi site, [...]
RESULTATS DU PREMIER SEMESTRE 2024 - Le plan stratégique Focus-27 est en bonne voie avec une exécution dans les délais de la feuille de route opérationnelle
30/07/2024
COMMUNIQUE DE PRESSE Paris, le 30 juillet 2024 Chiffre d’affaires en baisse de 9,6 % en variation annuelle - Marge de Core EBITDA de 10,6% Accélération de la dynamique commerciale avec les clients autres que Sanofi, [...]
La Croix-Rouge canadienne annonce une aide financière pour les personnes évacuées de Jasper en raison des feux de forêt en Alberta
30/07/2024
Les ménages contraints d’évacuer leur résidence principale à Jasper recevront 750 $ OTTAWA, Ontario, 30 juill. 2024 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne a annoncé aujourd’hui qu’elle versera un montant unique [...]
BioPorto Announces NIH-Funded Study to Explore the Ability of Renal Biomarkers in Predicting Severe AKI, Advancing Beyond NLP-based AI Algorithms
30/07/2024
July 30, 2024 News Release BioPorto Announces NIH-Funded Study to Explore the Ability of Renal Biomarkers in Predicting Severe AKI, Advancing Beyond NLP-based AI Algorithms ADLM 2024 Conference – Chicago, July 30, 2024 [...]
Ostomy Care Brand Revel Launches Groundbreaking Deodorizing Lubricant
30/07/2024
The Brand’s Debut Product Offers Cutting-edge Technology For Pancaking Prevention and Cleaner Pouch Empties Woburn, MA, July 30, 2024 (GLOBE NEWSWIRE) -- Revel, a pioneering brand in ostomy care, has launched its first [...]
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited Distribution Partner for Partner of ALYGLO™ for Adults With Primary Humoral Immunodeficiency (PI)
30/07/2024
CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA, Inc. as a limited distribution partner to [...]
AMN Healthcare Introduces Televate™ Teletherapy Platform for Students K-12
30/07/2024
New Technology to Expand Access to Therapy in High-Need Areas DALLAS, July 30, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare, the nation’s leading healthcare workforce solutions company, is introducing a new teletherapy [...]
Texicare Selects CirrusMD to Provide Access to On-Demand Virtual Care for Small Employer Groups in Texas
30/07/2024
CirrusMD's comprehensive virtual care solution addresses primary, acute, behavioral health and chronic healthcare needs DENVER, July 30, 2024 (GLOBE NEWSWIRE) -- CirrusMD, creator of the Physician-first Care & [...]
Acentra Health Honored as an AWS Champion for Digital Transformation in the Public Health Sector
30/07/2024
Company is the only public health sector-focused technology partner recognized for its use of cloud-native solutions to improve efficiency and outcomes MCLEAN, Va., July 30, 2024 (GLOBE NEWSWIRE) -- Acentra Health , a [...]
Marius Pharmaceuticals Submits KYZATREX® (Testosterone Undecanoate) CIII Capsules for Approval to Health Canada
30/07/2024
RALEIGH, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals , a patient-centric healthcare company focused on developing innovative therapies for Testosterone Deficiency, is pleased to announce the [...]
Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates
30/07/2024
FORT WORTH, TX, July 30, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused [...]
Outlook Therapeutics® to Present at the BTIG Virtual Biotechnology Conference 2024
30/07/2024
Company to participate in a fireside chat on Monday, August 5 th at 8:00 AM ET ISELIN, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on [...]
Arch Biopartners Arranges Non-Brokered Private Placement
29/07/2024
TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement offering of 400,000 common [...]
Earth Science Tech, Inc., Reports its June 30, 2024, Quarter Results, Recording Over $8.5M in Revenue and $1.07M in Net Profit
29/07/2024
Miami, FL, July 29, 2024 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a holding entity currently focused on the health and wellness industry, today shares its financial results from [...]
Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
29/07/2024
IRVINE, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients [...]
Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024
29/07/2024
ADELAIDE, Australia and CAMBRIDGE, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric [...]
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024
29/07/2024
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024 Mont-Saint-Guibert, Belgium – July 29, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the [...]
Nyxoah Publiera ses Résultats Financiers pour le Deuxième Trimestre Et le Premier Semestre 2024 le 6 Août 2024
29/07/2024
Nyxoah Publiera ses Résultats Financiers pour le Deuxième Trimestre Et le Premier Semestre 2024 le 6 Août 2024 Mont-Saint-Guibert, Belgique – 29 juillet 2024, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq [...]
Tilray Brands Reports Record Financial Results, Achieves 26% Net Revenue Growth
29/07/2024
Record Fiscal 2024 Gross Profit Reduced Net Convertible Debt by ~$300 Million in Fiscal 2024 Fiscal 2024 Net Revenue Reaches $789 Million, Led by Cannabis Net Revenue of $273 Million and Beverage-Alcohol Net Revenue of [...]

Pages